EyePoint
Develops sustained-release retinal therapies built around DURAVYU and Durasert E technology.
$4.51
After-hours close+0.03 (+0.74%)
At close$4.48(−3.35%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 113.12%Insiders 0.81%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 83.84M · Float 70.47M · 84.1% free float
Institutions13F, as of Jun 30, 2026
209 holders · 94.84M shares · 28 new positions · 94 increased · 61 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8.30M | 9.90% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 7.46M | 8.90% | +285.9K | Aug 7, 2026 |
| Cormorant Asset Management, LP | 7.00M | 8.35% | −1.27M | Aug 14, 2026 |
| Federated Hermes, Inc. | 5.68M | 6.78% | +11.5K | Aug 12, 2026 |
| Adage Capital Partners GP, L.L.C. | 4.83M | 5.76% | +1.53M | Aug 14, 2026 |
| Franklin Resources Inc | 4.81M | 5.73% | −241.5K | Aug 13, 2026 |
| Commodore Capital LP | 4.60M | 5.49% | +1.78M | Aug 14, 2026 |
| Jupiter Topco LLC | 3.77M | 4.50% | +3.77Mnew | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 9.98% | 8.27M | 13G | Dec 8, 2025 ↗ |
| BlackRock, Inc. | 7.80% | 4.16M | Oct 22, 2024 ↗ | |
| Federated Hermes, Inc. | 6.68% | 4.60M | 13G | Jul 8, 2025 ↗ |
| Franklin Resources, Inc. | 6.10% | 4.14M | 13G | Jan 27, 2025 ↗ |
| TCG Crossover Fund II, L.P.incl. Chen Yu, TCG Crossover GP II, LLC | 5.20% | 3.57M | 13G | Nov 7, 2024 ↗ |
| Vanguard Capital Management | 5.03% | 4.22M | 13G | Jul 31, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Cormorant Asset Management, LP | other: Former 10% Owner | 8.27M | 9.86% | Dec 8, 2025 |
| Nancy Lurker | director | 346.6K | 0.41% | Jan 7, 2026 |
| Jay S. Duker | director, officer: President and CEO | 187.0K | 0.22% | Jul 14, 2026 |
| George Elston | officer: Chief Financial Officer | 97.5K | 0.12% | Aug 24, 2026 |
| Karen L. Zaderej | director | 49.1K | 0.06% | Aug 18, 2026 |
4 ten-percent owners hold 18.77M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 22 people have not refiled in the last 18 months (1.33M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 18, 2026 | Karen L. Zaderejdirector | Purchase | 10,600 | $4.93 | 49,100 |
| Jun 30, 2026 | Ramiro Ribeiroofficer: Chief Medical Officer | Sale · 2 lots | 4,875 | $15.01 | 0 |
| Apr 17, 2026 | Ramiro Ribeiroofficer: Chief Medical Officer | Sale | 2,437 | $15.00 | 0 |
| Mar 16, 2026 | Jay S. Dukerdirector, officer: President and CEO | Purchase | 1,500 | $13.15 | 100,665 |
| Mar 4, 2026 | Ramiro Ribeiroofficer: Chief Medical Officer | Sale | 2,438 | $17.87 | 0 |
| Feb 17, 2026 | Ramiro Ribeiroofficer: Chief Medical Officer | Sale | 2,437 | $15.00 | 0 |
| Jan 5, 2026 | Ramiro Ribeiroofficer: Chief Medical Officer | Sale | 42,544 | $17.10 | 0 |
| Dec 4, 2025 | Cormorant Asset Management, LPother: Former 10% Owner | Sale | 60,000 | $15.70 | 8,265,000 |
| Dec 4, 2025 | Nancy Lurkerdirector | Sale | 9,300 | $15.11 | 206,547 |
| Nov 28, 2025 | Nancy Lurkerdirector | Sale | 500 | $14.95 | 215,847 |
CongressHouse and Senate disclosures
Not reported.